China's infusion plastic packaging has become a new development

Pharmaceutical packaging has become an important branch of China's packaging industry. At present, the annual value of pharmaceutical packaging in China is around 15 billion yuan, and infusion plastic packaging has become a new development.

The development prospects of solid dosage form packaging for pharmaceuticals account for the relevant statistical data. The annual output value of pharmaceutical packaging in China is around 15 billion yuan. At present, pharmaceutical packaging has become an important branch of China's packaging industry. With the reform of the medical system in China, the types of drugs have increased, and the form of pharmaceutical packaging has also changed. From the original paper bag packaging, plastic bag packaging, glass bottles to the current polyethylene bottles, polypropylene bottles, polyester bottles, aluminum plastic packaging, strip packaging, reversed the backward situation of drug packaging.

Foreign pharmaceutical packaging has been widely used in steam hood PTP packaging and strip SP packaging, used in solid dosage forms such as tablets and capsules. In China, the packaging of pharmaceutical steam hoods and strip composite film packaging will also become mainstream and have a broad development perspective.

Infusion plastic packaging has become a new development trend China's current large infusion 90% of the use of glass packaging, soft plastic packaging, the actual production of less than 200 million bottles (bags). At present, most foreign infusions are packed in high quality plastic bottles or plastic bags. As China has entered the WTO, foreign-funded hospitals have increased, and the number of foreigners who come to live in China has also continued to increase, and the demand has greatly increased. The per capita use of infusion volume in developed countries was 3.33 bottles, which is undoubtedly a very large market space. At present, the world's largest infusion production volume is 12 billion bottles, and China is only 3 billion bottles. Therefore, since 2001, the expansion, expansion, and production of infusion packaging have become “hot spots,” and the plastic packaging industry is no exception.

Infusion packaging is mainly divided into plastic bottles and plastic bags. Since the beginning of the year, BOPP bottles have risen to the fore, with Dongguan Jiahong Machinery Co., Ltd. developing domestically produced BOPP infusion bottle manufacturing equipment, adopting two-step injection and blowing PP bottle production equipment, producing 2200 to 2500 bottles per hour, which is welcomed by pharmaceutical users. In combination with other sterilization and filling equipment, BOPP infusion bottles have shown a growing trend and have changed the situation in which glass bottles dominate the world. It is expected that the production capacity of BOPP bottles already existing and under construction (17 introduction of 20 plastic bottle production lines) will exceed 1 billion bottles by the end of next year, and will form diversified pharmaceutical liquid packaging together with glass bottles and soft plastic bags.

Soft plastic bags, according to incomplete statistics, at present, a total of 21 companies to introduce or sign a flexible plastic packaging production line 25, soft plastic bag production capacity will reach 300 million bags.

In view of the above, the plastic packaging companies that are currently implementing or preparing for the project must carefully consider that the pharmaceutical packaging adopts an advancing system and has strict requirements on the quality and technology of packaging materials. However, (medicine plastics, infusion plastic packaging materials and container standards) have not yet been introduced, and it is difficult for users to select packaging materials for quality assurance. Easy to produce disorderly competition. Therefore, we must carefully consider and avoid causing economic losses.